STIM2 is involved in the regulation of apoptosis and the cell cycle in normal and malignant monocytic cells
Molecular Oncology · 2024
DOI: 10.1002/1878-0261.13584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2024. Verfasst von Stefan Djordjevic und 12 weiteren Autor:innen. Beteiligte Einrichtung: HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France. Hauptthemen laut MEDLINE: Apoptosis, Monocytes, Leukemia, Myeloid, Acute, Stromal Interaction Molecule 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cent pour Sang la Vie Journée contre la Leucémie, Journée contre la Leucémie, La Ligue contre le Cancer Comité Septentrion.
Abstract (Originalsprache)
Calcium is a ubiquitous messenger that regulates a wide range of cellular functions, but its involvement in the pathophysiology of acute myeloid leukemia (AML) is not widely investigated. Here, we identified, from an analysis of The Cancer Genome Atlas and genotype‐tissue expression databases, stromal interaction molecule 2 ( STIM2 ) as being highly expressed in AML with monocytic differentiation and negatively correlated with overall survival. This was confirmed on a validation cohort of 407 AML patients. We then investigated the role of STIM2 in cell proliferation, differentiation, and survival in two leukemic cell lines with monocytic potential and in normal hematopoietic stem cells. STIM2 expression increased at the RNA and protein levels upon monocyte differentiation. Phenotypically, STIM2 knockdown drastically inhibited cell proliferation and induced genomic stress with DNA double‐strand breaks, as shown by increased levels of phosphorylate histone H2AXγ (p‐H2AXγ), followed by activation of the cellular tumor antigen p53 pathway, decreased expression of cell cycle regulators such as cyclin‐dependent kinase 1 (CDK1)–cyclin B1 and M‐phase inducer phosphatase 3 (CDC25c), and a decreased apoptosis threshold with a low antiapoptotic/proapoptotic protein ratio. Our study reports STIM2 as a new actor regulating genomic stability and p53 response in terms of cell cycle and apoptosis of human normal and malignant monocytic cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France.
- Département Hématologie et Immunologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, France.
- Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Université Paris Cité, France.
- Laboratoire de Physiologie Cellulaire et Moléculaire UR4667, Université Picardie Jules Verne, Amiens, France.
- Service d'Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens-Picardie, France.
- Laboratoire de Génétique Constitutionnelle, CHU Amiens-Picardie, France.
ORCID-Profile: Stefan Djordjevic, Loïc Garçon
Förderung
- Cent pour Sang la Vie Journée contre la Leucémie
- Journée contre la Leucémie
- La Ligue contre le Cancer Comité Septentrion
Zitieren
APA
Djordjevic, S., Itzykson, R., Hague, F., Lebon, D., Legrand, J., Ouled-Haddou, H., Jedraszak, G., Harbonnier, J., Collet, L., Paubelle, E., Marolleau, J. P., Garçon, L., & Boyer, T. (2024). STIM2 is involved in the regulation of apoptosis and the cell cycle in normal and malignant monocytic cells. Molecular Oncology. https://doi.org/10.1002/1878-0261.13584
Vancouver
Djordjevic S, Itzykson R, Hague F, Lebon D, Legrand J, Ouled-Haddou H, et al. STIM2 is involved in the regulation of apoptosis and the cell cycle in normal and malignant monocytic cells. Molecular Oncology. 2024. doi:10.1002/1878-0261.13584
BibTeX
@article{Djordjevic2024,
author = {Djordjevic, Stefan and Itzykson, Raphaël and Hague, Frédéric and Lebon, Delphine and Legrand, Julien and Ouled-Haddou, Hakim and Jedraszak, Guillaume and Harbonnier, Juliette and Collet, Louison and Paubelle, Etienne and Marolleau, Jean-Pierre and Garçon, Loïc and Boyer, Thomas},
title = {STIM2 is involved in the regulation of apoptosis and the cell cycle in normal and malignant monocytic cells},
journal = {Molecular Oncology},
year = {2024},
doi = {10.1002/1878-0261.13584}
}
EUVIMED